Webster Brian Daniel 4
4 · KESTRA MEDICAL TECHNOLOGIES, LTD. · Filed May 18, 2026
Research Summary
AI-generated summary of this filing
Kestra Medical (KMTS) CEO Brian Webster Sells 15,000 Shares
What Happened
Brian Daniel Webster, President, Chief Executive Officer and a director of Kestra Medical Technologies, sold a total of 15,000 shares in two open-market transactions on May 15, 2026. He sold 8,155 shares at $20.53 per share (proceeds $167,412) and 6,845 shares at $21.46 per share (proceeds $146,918), for aggregate proceeds of approximately $314,330. These were sales (not purchases), which are often routine dispositions.
Key Details
- Transaction date: 2026-05-15; Form 4 filed: 2026-05-18 (within normal reporting timeframe).
- Trade breakdown:
- 8,155 shares sold at $20.53 — reported proceeds $167,412. (Footnote: weighted-average price; reported price range $20.2200 to $20.2115.)
- 6,845 shares sold at $21.46 — reported proceeds $146,918. (Footnote: weighted-average price; reported price range $21.2433 to $21.6300.)
- Total shares sold: 15,000; total proceeds: ~$314,330.
- Reported as occurring under a Rule 10b5‑1 trading plan adopted September 29, 2025 (pre-arranged trading plan).
- Shares owned after the transaction are not specified in the summary provided.
Context
Sales executed under a 10b5‑1 plan are pre-scheduled and commonly used by insiders to systematically sell holdings; they do not necessarily indicate a change in view on the company. This filing documents routine insider selling rather than a purchase or option exercise.
Insider Transaction Report
- Sale
Common Shares
[F1][F2]2026-05-15$20.53/sh−8,155$167,412→ 341,631 total - Sale
Common Shares
[F1][F3]2026-05-15$21.46/sh−6,845$146,918→ 334,786 total
Footnotes (3)
- [F1]The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025.
- [F2]The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $20.2200 to $20.2115. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.
- [F3]The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $21.2433 to $21.6300. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.